Vivet Therapeutics Alternatives & Competitors
12 companies similar to Vivet Therapeutics — Vivet Therapeutics develops gene therapy treatments for inherited liver disorder...
Companies similar to Vivet Therapeutics
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Spur Therapeutics
Toward the next generation of gene therapy.
Stevenage, United Kingdom
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
克睿基因 Cure Genetics
Benifiting Lives with Genetic Engineering
China
Rival Readout
Competing with Vivet Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ultragenyx
Going Beyond Every Day
Novato, United States
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
Monrovia, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
South San Francisco, Unit...
BridgeBio
We move at the speed of patient need.
Palo Alto, United States
About Vivet Therapeutics
Vivet Therapeutics is a pioneering company within the Biopharma and Biotechnology industries, solidifying its focus on advancing innovative gene therapy treatments specifically for inherited liver disorders. Established in 2016, the company has positioned itself as a leader in treating orphan diseases using the proprie...
Development of transformative gene therapies, AAV-based therapeutic technologies, Research and clinical trials focused on rare diseases, Patient advocacy and support in rare genetic disorders
Patients with rare genetic disorders, Healthcare professionals in gene therapy, Biotechnology partners, Investors in healthcare and biotechnology sectors
Gene Therapy, Inherited Liver Disorders, Orphan Diseases, Liver Tropic Virus, AAV Vectors, Liver Targeting, Gene Delivery Optimization, Long-term Expression, Collaborative Research, Biotechnology Innovation, Medical Research Partnership
B2B, B2D
Licensing, Performance Based, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vivet Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vivet Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
